What ENDO HEALTH SOLUTIONS INC.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| DeGolyer Donald W | Chief Operating Officer,Pharma | Feb 28 | Disposition to Issuer · D | −10,242 | — | — | 0 |
| DeGolyer Donald W | Chief Operating Officer,Pharma | Feb 28 | Disposition to Issuer · D | −30,604 | — | — | 0 |
| DeGolyer Donald W | Chief Operating Officer,Pharma | Feb 28 | Disposition to Issuer · D | −5,121 | — | — | 0 |
| DeGolyer Donald W | Chief Operating Officer,Pharma | Feb 28 | Disposition to Issuer · D | −30,604 | — | — | 0 |
| Higgins Arthur J | Director | Feb 28 | Disposition to Issuer · D | −1,016 | — | — | 0 |
| Smith Jill D. | Director | Feb 28 | Disposition to Issuer · D | −6,515 | — | — | 0 |
| Smith Jill D. | Director | Feb 28 | Disposition to Issuer · D | −3,084 | — | — | 0 |
| Upadhyay Suketu | EVP, Chief Financial Officer | Feb 28 | Disposition to Issuer · D | −10,147 | — | — | 0 |
| Upadhyay Suketu | EVP, Chief Financial Officer | Feb 28 | Disposition to Issuer · D | −15,418 | — | — | 0 |
| Upadhyay Suketu | EVP, Chief Financial Officer | Feb 28 | Disposition to Issuer · D | −5,073 | — | — | 0 |
| Upadhyay Suketu | EVP, Chief Financial Officer | Feb 28 | Disposition to Issuer · D | −15,418 | — | — | 0 |
| Gergel Ivan | EVP, R&D and CSO | Feb 28 | Disposition to Issuer · D | −8,690 | — | — | 0 |
| Gergel Ivan | EVP, R&D and CSO | Feb 28 | Disposition to Issuer · D | −15,952 | — | — | 0 |
| Gergel Ivan | EVP, R&D and CSO | Feb 28 | Disposition to Issuer · D | −13,441 | — | — | 0 |
| Gergel Ivan | EVP, R&D and CSO | Feb 28 | Disposition to Issuer · D | −5,982 | — | — | 0 |
| Gergel Ivan | EVP, R&D and CSO | Feb 28 | Disposition to Issuer · D | −6,720 | — | — | 0 |
| Gergel Ivan | EVP, R&D and CSO | Feb 28 | Disposition to Issuer · D | −3,329 | — | — | 0 |
| Gergel Ivan | EVP, R&D and CSO | Feb 28 | Disposition to Issuer · D | −27,649 | — | — | 0 |
| De Silva Rajiv | President & CEO | Feb 28 | Disposition to Issuer · D | −82,182 | — | — | 0 |
| De Silva Rajiv | President & CEO | Feb 28 | Disposition to Issuer · D | −82,182 | — | — | 0 |
Loading...
